試す - 無料

HITTING REFRESH

Mint Hyderabad

|

May 10, 2025

Six years after she had a stroke, designer Anamika Khanna is taking the slow and steady route to turn her couture and pret labels into global hits

- Pooja Singh

This is not the Anamika Khanna I met a few years ago. Back then, the Kolkata-based designer stuck to crisp one-line answers, and was uninterested in explaining herself. She preferred to let her work do all the talking.

The Anamika Khanna sitting before me this Friday afternoon, a few weeks before heading to New York to style Isha Ambani for the Met Gala, is chatty without oversharing. The collar of her oversized white shirt is up, her black trousers are tailored like a salwar, and the whole look is complemented by killer heels, blow-dried black hair and freshly manicured red-gel nails. It's this effortless feminine-yet-androgynous personal style that extends to her work.

"This is AK 2.0," says Khanna, the force behind the eponymous couture brand and ready-to-wear label AK-OK. "(There is) a 180-degree change in the way I now approach life and work," she says, before excusing herself to take a call from a client.

We are at her store in Kala Ghoda, Mumbai's arts district-turned-fashion hub where designers from Anita Dongre to Gaurav Gupta have built elaborate stores in heritage buildings. Khanna's store is in one of the more modern buildings. Lines of garments hang on exposed railings, surrounded by blank white walls—a rare sight of minimalism in a sea of stores adorned with chandeliers, elaborate wallpaper and plush carpets.

Khanna, 53, who started her career in Kolkata with an eponymous couture label in the late 1990s, stands out in the world of fashion entrepreneurs. She was the first woman in her traditional Marwari family to go to college (Loretto in Kolkata), work, and build one of the country's large couture brands. Her aesthetic is nonconformist—she peels back the layers of traditional silhouettes, rearranging them to create something unique that pushes you to see classic design in a new light.

Mint Hyderabad からのその他のストーリー

Mint Hyderabad

Mint Hyderabad

Nvidia, Eli Lilly to invest $1 bn in AI lab

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.

time to read

1 min

January 13, 2026

Mint Hyderabad

Shadowfax IPO to open next week

Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.

time to read

1 min

January 13, 2026

Mint Hyderabad

The US climate cop-out should galvanize others

America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US

time to read

2 mins

January 13, 2026

Mint Hyderabad

Toyota pushes for fuel norm clarity

The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.

time to read

1 min

January 13, 2026

Mint Hyderabad

Food effect lifts Dec CPI inflation

India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.

time to read

1 min

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Commissions trump advice in wealth management biz

surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.

time to read

2 mins

January 13, 2026

Mint Hyderabad

The Chinese company taking on the world's memory-chip giants

As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders

time to read

4 mins

January 13, 2026

Mint Hyderabad

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Hyderabad

Fix GST on capital goods to revive private investment

India faces a paradox today.

time to read

3 mins

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Feeling tired? It could be too many messages

The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes

time to read

4 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size